%% Created using Papers on Sun, 14 Jan 2018.
%% http://papersapp.com/papers/

@article{Boyce:2000gz,
author = {Boyce, T G and Mellen, B G and Mitchel, E F and Wright, P F and Griffin, M R},
title = {{Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.}},
journal = {The Journal of pediatrics},
year = {2000},
volume = {137},
number = {6},
pages = {865--870},
month = dec
}

@misc{Anonymous:1998up,
title = {{Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn.}},
month = nov,
year = {1998}
}

@article{Hampp:2011ju,
author = {Hampp, Christian and Kauf, Teresa L and Saidi, Arwa S and Winterstein, Almut G},
title = {{Cost-effectiveness of respiratory syncytial virus prophylaxis in various indications.}},
journal = {Archives of pediatrics {\&} adolescent medicine},
year = {2011},
volume = {165},
number = {6},
pages = {498--505},
month = jun
}

@article{Group:1998ih,
author = {Group, The IMpact-RSV Study},
title = {{Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants}},
journal = {Pediatrics},
year = {1998},
volume = {102},
number = {3},
pages = {531--537},
month = sep
}

@article{Hall:2009gi,
author = {Hall, Caroline Breese and Weinberg, Geoffrey A and Iwane, Marika K and Blumkin, Aaron K and Edwards, Kathryn M and Staat, Mary A and Auinger, Peggy and Griffin, Marie R and Poehling, Katherine A and Erdman, Dean and Grijalva, Carlos G and Zhu, Yuwei and Szilagyi, Peter},
title = {{The burden of respiratory syncytial virus infection in young children.}},
journal = {The New England journal of medicine},
year = {2009},
volume = {360},
number = {6},
pages = {588--598},
month = feb
}

@article{AmericanAcademyofPediatricsCommitteeonInfectiousDiseases:2014bj,
author = {{American Academy of Pediatrics Committee on Infectious Diseases} and {American Academy of Pediatrics Bronchiolitis Guidelines Committee}},
title = {{Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.}},
journal = {Pediatrics},
year = {2014},
volume = {134},
number = {2},
pages = {e620--38},
month = aug
}

@article{Feltes:2003wm,
author = {Feltes, Timothy F and Cabalka, Allison K and Meissner, H Cody and Piazza, Franco M and Carlin, David A and Top, Franklin H and Connor, Edward M and Sondheimer, Henry M and {Cardiac Synagis Study Group}},
title = {{Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease.}},
journal = {The Journal of pediatrics},
year = {2003},
volume = {143},
number = {4},
pages = {532--540},
month = oct
}

@techreport{Meissner:2003ug,
author = {Meissner, H Cody and Long, Sarah S and {American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn}},
title = {{Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.}},
year = {2003},
month = dec
}

@article{Noveroske:y4fi3188,
author = {Noveroske, Douglas Brian},
title = {{Respiratory Syncytial Virus In Connecticut: Predictors Of Seasonal Epidemic Timing}},
journal = {Public Health Theses},
year = {2016}
}

@article{Resch:1999ek,
author = {Resch, B and M{\"u}ller, W},
title = {{[Prophylaxis of respiratory syncytial virus (RSV) in preterm infants with/without bronchopulmonary dysplasia: hyperimmune globulin (RSV-IGIV) and palivizumab (MEDI-493)].}},
journal = {Klinische Padiatrie},
year = {1999},
volume = {211},
number = {6},
pages = {450--455},
month = nov
}

@article{Zhou:2012ho,
author = {Zhou, Hong and Thompson, William W and Viboud, Cecile G and Ringholz, Corinne M and Cheng, Po-Yung and Steiner, Claudia and Abedi, Glen R and Anderson, Larry J and Brammer, Lynnette and Shay, David K},
title = {{Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.}},
journal = {Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
year = {2012},
volume = {54},
number = {10},
pages = {1427--1436},
month = may
}

@article{Andabaka:2013dr,
author = {Andabaka, Tea and Nickerson, Jason W and Rojas-Reyes, Maria Ximena and Rueda, Juan David and Bacic Vrca, Vesna and Barsic, Bruno},
title = {{Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children.}},
journal = {The Cochrane database of systematic reviews},
year = {2013},
volume = {28},
number = {4},
pages = {CD006602},
month = apr
}

@article{Hall:2013jo,
author = {Hall, Caroline Breese and Weinberg, Geoffrey A and Blumkin, Aaron K and Edwards, Kathryn M and Staat, Mary A and Schultz, Andrew F and Poehling, Katherine A and Szilagyi, Peter G and Griffin, Marie R and Williams, John V and Zhu, Yuwei and Grijalva, Carlos G and Prill, Mila M and Iwane, Marika K},
title = {{Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.}},
journal = {Pediatrics},
year = {2013},
volume = {132},
number = {2},
pages = {e341--8},
month = aug
}

@misc{AmericanAcademyofPediatricsCommitteeonInfectiousDiseasesandCommitteeonFetusandNewborn:2003ug,
title = {{Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.}},
author = {{American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn}},
month = dec,
year = {2003}
}

@article{AmericanAcademyofPediatricsCommitteeonInfectiousDiseasesandCommitteeonFetusandNewborn:2003ug,
author = {{American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn}},
title = {{Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections.}},
journal = {Pediatrics},
year = {2003},
volume = {112},
number = {6 Pt 1},
pages = {1442--1446},
month = dec
}

@webpage{CentersforDiseaseControlandPrevention:368RENtm,
author = {{Centers for Disease Control and Prevention}},
title = {{Respiratory Syncytial Virus Infection (RSV): For Healthcare Professionals}},
url = {https://www.cdc.gov/rsv/clinical/index.html}
}

